Search research articles
Contact Us
Filters
Showing results (531-540 of 593) with videos related to
Page
of 60
Sort By:
Angewandte Chemie (International Ed. in English)
|
January 31, 2018
Conformation-Enabled Total Syntheses of Ohmyungsamycins A and B and Structural Revision of Ohmyungsamycin B
Joonseong Hur, Jaebong Jang, Jaehoon Sim, et al.
Journal of Medicinal Chemistry
|
April 6, 2017
N<sup>6</sup>-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A<sub>3</sub> Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation
Jinha Yu, Long Xuan Zhao, Jongmi Park, et al.
Cancer Research
|
August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
Practical Radiation Oncology
|
November 18, 2024
Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer
Ambrosia Simmons, David Sher, Dr Dong Wook Nathan Kim, et al.
World Journal of Clinical Oncology
|
September 13, 2023
Targeting <i>KRAS</i> in pancreatic adenocarcinoma: Progress in demystifying the holy grail
Ahmed Elhariri, Ahmed Alhaj, Daniel Ahn, et al.
Contemporary Clinical Trials
|
January 14, 2024
Preventing cognitive decline by reducing BP target (PCOT): A randomized, pragmatic, multi-health systems clinical trial
John M Giacona, Brooke M Bates, Venkatraghavan Sundaram, et al.
Cancers
|
February 24, 2024
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy
Sunshin Kim, Youngjoo Lee, Bo Ram Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2016
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer
Matthew R Farren, Thomas A Mace, Susan Geyer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical Trial
Asal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
Scientific Reports
|
December 29, 2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, et al.
Page
of 60
Search research articles
Search
Showing results (531-540 of 593) with videos related to
Sort By:
Page
of 60
Angewandte Chemie (International Ed. in English)
|
January 31, 2018
Conformation-Enabled Total Syntheses of Ohmyungsamycins A and B and Structural Revision of Ohmyungsamycin B
Joonseong Hur, Jaebong Jang, Jaehoon Sim, et al.
Journal of Medicinal Chemistry
|
April 6, 2017
N<sup>6</sup>-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A<sub>3</sub> Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation
Jinha Yu, Long Xuan Zhao, Jongmi Park, et al.
Cancer Research
|
August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
Practical Radiation Oncology
|
November 18, 2024
Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer
Ambrosia Simmons, David Sher, Dr Dong Wook Nathan Kim, et al.
World Journal of Clinical Oncology
|
September 13, 2023
Targeting <i>KRAS</i> in pancreatic adenocarcinoma: Progress in demystifying the holy grail
Ahmed Elhariri, Ahmed Alhaj, Daniel Ahn, et al.
Contemporary Clinical Trials
|
January 14, 2024
Preventing cognitive decline by reducing BP target (PCOT): A randomized, pragmatic, multi-health systems clinical trial
John M Giacona, Brooke M Bates, Venkatraghavan Sundaram, et al.
Cancers
|
February 24, 2024
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy
Sunshin Kim, Youngjoo Lee, Bo Ram Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2016
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer
Matthew R Farren, Thomas A Mace, Susan Geyer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical Trial
Asal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
Scientific Reports
|
December 29, 2019
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma
Seok-Young Kim, Ji Yeon Lee, Dong Hwi Kim, et al.
Page
of 60